A discovery by Montreal researchers is expected to improve the diagnosis and treatment of patients with myalgic encephalomyelitis (ME), better known as chronic fatigue syndrome.
In most instances, ME is currently diagnosed by elimination, as doctors put aside other possible causes of the patient’s symptoms.
But researchers from the University of Montreal and the CHU Sainte-Justine, led by Professor Alain Moreau, have found a blood biomarker that can help identify patients with ME.
To read the rest of this story, click on the link below:
Time For Unrest: Why Patients With ME Are Demanding Justice.
